ubiquinone
3 interactions related to ubiquinone
simvastatin + coq10
Simvastatin inhibits HMG-CoA reductase, the enzyme upstream of both cholesterol and coenzyme Q10 synthesis. This produces a measurable decline in circulating CoQ10 and may contribute to mitochondrial dysfunction underlying statin-associated muscle symptoms.
rosuvastatin + coq10
Rosuvastatin blocks HMG-CoA reductase, an enzyme required for both cholesterol and coenzyme Q10 synthesis. Although the CoQ10 depletion is generally smaller than with lipophilic statins, mitochondrial impairment is still one proposed mechanism for statin-associated muscle symptoms.
atorvastatin + coq10
Atorvastatin inhibits HMG-CoA reductase, the same upstream enzyme required to synthesize coenzyme Q10 (ubiquinone). Plasma CoQ10 levels can drop by 30-40% with atorvastatin therapy, and the resulting mitochondrial dysfunction is one proposed mechanism for statin-associated muscle symptoms.